Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

A Darker Side to Diabetes: 51% of Patients Have Been Treated for Stress or Mental Health Issues, According to New Survey by Ieso

Ieso Digital Health
Posted on: 14 May 18
A Darker Side to Diabetes: 51% of Patients Have Been Treated for Stress or Mental Health Issues, According to New Survey by Ieso

PR Newswire

CAMBRIDGE and LONDON, England, May 14, 2018

CAMBRIDGE and LONDON, England, May 14, 2018 /PRNewswire/ --

Ahead of UK Mental Health Awareness Week 2018 (14 th to 21 st May), a n independent s urvey of people diagnosed with type 1 and 2 diabetes , commissioned by Ieso Digital Health highlight s the scale of stress and mental health problems affect ing those living with this chronic condition. 

  • Three quarters (75%) of young adults (16-34) believe that their mental health has been negatively affected by their diabetes   
  • Almost half (46%) sa y that more awareness of diabetes-specific mental health issues would help prevent high levels of stress , anxiety and depression and other mental health problems, associated with having diabetes
  • 43% say mental health education and assessment should b e integrated into on-going diabetes health care 

Around 700 people get diagnosed with diabetes every day in the UK. That's the equivalent of one person every two minutes[i]. This survey, compiled by Ieso Digital Health, the UK's largest provider of online CBT, shows that people living with diabetes are more likely to experience mental health problems compared with the general population. About one in four adults in the UK will suffer from a mental health condition each year[ii]; however the Ieso survey found that over half of patients with diabetes (51 per cent) have sought treatment for stress, anxiety, depression or other mental health problems. Three quarters (75%) of young adults (16-34) believe their mental health has been negatively affected by their diabetes.

     (Photo: )

     (Photo: )

According to Sarah Bateup, Chief Clinical Officer, Ieso Digital Health, "Mental health should be considered an integral part of on-going diabetes care.  We need to ensure a multifaceted approach including comprehensive assessment for mental health problems, educating patients to recognise stress and mental health problems and encouraging self‐care. Providing effective mental health interventions such as cognitive behavioural therapy (CBT) can help patients to address the emotional and behavioural aspects of living with a life-long condition such as diabetes."  

M ental he alth issues can make it more difficult for diabetes sufferers to alter their diet and lifestyle to comply with medical treatment programmes . 

Mental health issues linked to diabetes include feelings of loss, stress, anger, panic attacks, mood disorders, depression, anxiety and eating disorders[iii]. A depressed person is less likely to adhere to their diabetes medication or monitoring regimens which are necessary for effective management of diabetes, resulting in poor glycaemic control. Phobic symptoms or anxieties related to self-injection of insulin and self-monitoring of blood glucose are common, resulting in further emotional distress. Stress and depression are known to elevate blood glucose levels, even if medication is taken regularly.

Diagnosed with diabetes? Call to treat the whole patient, not just the physical symptoms. 

Almost half of people (46%) of people believe that better awareness would help detect stress and mental health issues, while 43% think discussions of mental health within diabetes-specific appointments would help and that clearer advice from medical bodies would help.  

Ieso patient John Riley said, "Mentally diabetes really got to me. The term 'life-long', hit me hard when I was first diagnosed and facing the prospect of having to inject myself every day for the rest of my life. I felt I was out on my own and got quite down and depressed. The tools the therapist gave me have really helped me to cope and the best thing is I can still access my account and review the things we spoke about. I would really recommend Ieso to others."

Notes to Editors 

Diabetes Data and Scientific R eferences 

i. McManus, S., Meltzer, H., Brugha, T. S., Bebbington, P. E., & Jenkins, R. (2009). Adult psychiatric morbidity in England, 2007: results of a household survey. The NHS Information Centre for health and social care.

ii. A Review of the Mental Health Issues of Diabetes, Lee Ducat et al, Diabetes Care 2015

iii. Depression Among Adults With Diabetes, Katon WJ et al, Diabetes Care 2010

About Ieso ' s S urvey ' A Dark er Side to Diabetes ' 

This survey was commissioned by Ieso in April 2018 and conducted by Censuswide, an independent research firm and member of Market Research Society. The survey involved interviews from more than 500 people diagnosed with type 1 and type 2 diabetes, aged 16 years or older.

About Ieso Digital Health 

Ieso is the leading provider of online mental healthcare in the UK. Ieso is redefining the way that mental healthcare is delivered by making high quality cognitive behavioural therapy (CBT) accessible, accountable and affordable.  Ieso's unique modality has been clinically validated in a trial published in The Lancet in 2009. Online CBT mirrors face-to-face therapy and involves real-time personalised communication between therapist and patient in therapy sessions. Ieso is available through the NHS Improving Access to Psychological Therapies (IAPT) programme. Ieso is a multi-award winning business and begins 2018 as one of UK's fastest-growing technology companies, as lauded in the Deloitte Fast 50 competition. Ieso has also been recognised as one of the Sunday Times Disruptors to Watch and also was awarded the accolade of 2017 Digital Innovation of the Year. Launched into the US in 2017, the company is accelerating penetration there with a blue-chip management team with deep industry pedigree. For more information visit

Background Information 

About Mental Health Awareness Week 14 th to 20 th May 2018 : 

  • Mental Health Awareness week is run by the Mental Health Foundation (MHF).  This year the theme is 'Stress: Are we coping?' According to MHF research stress plays a key factor for the 16 million people who experience a mental health problem each year in the UK.  
  • By tackling stress, MHF maintain we can go a long way to tackling mental health problems such as anxiety and depression and in some instances self-harm and suicide. Stress makes people more likely to engage in unhealthy coping strategies, like drinking, overeating and unhealthy eating.

Diabetes Facts UK : 

  • Since 1996, the number of people diagnosed with diabetes in the UK has more than doubled from 1.4 million to almost 3.7 million.
  • There are an estimated 4.5 million people with diabetes in the UK. This includes 1 million people with Type 2 diabetes who don't know they have it because they have not been diagnosed.
  • According to the NHS, the number of people with the condition has nearly trebled since 1996 and around five million people will have diabetes by the year 2025.

Public figures, C elebrities and S ports people living with d iabetes :  

  • Politicians include Prime Minister Theresa May (type 1), Labour party MP Chuka Umunna (type 1), former Labour party MP Jamie Reed (type 1) and former Liberal Democrat MP Adrian Sanders (type 1).
  • Celebrities include actor Tom Hanks (type 2), actor Salma Hayek (gestational diabetes, TV presenter Dominic Littlewood (type 1), X Factor singer Amelia Lily (type 1), actor Halle Berry (type 1), singer Nick Jonas (type 1), actor James Norton (type 1) and celebrity chef, Antony Worrall Thompson (type 2).
  • Sports stars include cricketer Wasim Akram (type 1), footballer Gary Mabbutt (type 1) Olympic medallist Sir Steven Redgrave (type 1), rugby union player Henry Slade (type 1).

For further information or interview requests with Ieso please contact:    

C: Simon Merritt
M: +44-7967-251850

C: Rachel Dalton
M: +353-863825895

PR Newswire

Last updated on: 14/05/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.